Avai Bio (AVAI) Return on Equity (2018 - 2025)

Avai Bio has disclosed Return on Equity across 8 years of filings, most recently posting 0.02% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.02%, up 4.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02% (up 4.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
• Return on Equity came in at 0.02% for Q4 2025 at Avai Bio, down from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 2.77% in Q3 2021 to a low of 0.15% in Q1 2025.
• The 5-year median for Return on Equity is 0.02% (2023), against an average of 0.16%.
• Across the five-year window, Return on Equity surged 277 bps in 2021 and tumbled 278 bps in 2022, its largest moves.
• Avai Bio's Return on Equity stood at 0.0% in 2021, then retreated by 12 bps to 0.0% in 2022, then surged by 602 bps to 0.02% in 2023, then tumbled by 216 bps to 0.03% in 2024, then surged by 159 bps to 0.02% in 2025.
• The last three Return on Equity figures came in at 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025), per Business Quant data.